(Via Newsy) – Initial human trials of an experimental ebola vaccine show promise, according to researchers at the National Institutes of Health.
A recent study exposed 20 healthy adults to the prototype drug, which was supposed to trigger an immune system response to Ebola.
According to a report published in the New England Journal of Medicine Wednesday, each patient showed antibody response “in the range reported to be associated with vaccine-induced protective immunity…” In other words, it appears to have worked.
The NIH worked with pharmaceutical company GlaxoSmithKline to accelerate the potential vaccine through to human testing phases.
Story continues at Newsy.
Watch this video report from Newsy: